Technology area: Biotechnology & Pharmaceuticals
9 pending office actions • 8 art units • 8 examiners • 0 of 9 (0%) have an AI response strategy ready • 43 patents granted in the last 365 days
The Florida International University Board of Trustees currently has 7 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 7 distinct examiners and 7 distinct art units. This distribution of 7 pending office actions among 7 distinct examiners suggests that every matter is being reviewed by a different official. The involvement of 7 distinct art units indicates that the university's biotechnology research is classified across many specialized areas of the patent office.
The busiest examiner for this portfolio is COLEMAN, BRENDA LIBBY, who is responsible for 1 busiest examiner pending action. Because there are 7 distinct examiners for the 7 pending office actions, the workload is highly distributed. This decentralization across 7 distinct art units means that the portfolio is subject to a wide range of technical standards and examiner perspectives. Practitioners must manage relationships with 7 distinct examiners to advance these 7 pending actions.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (11%) |
| §101 + other | 2 (22%) |
| §103 only | 2 (22%) |
| Multi-statute (no §101) | 2 (22%) |
| No statute on record | 2 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WANG, CHANG YU | 2 | 33.4% | +53.7% |
| COLEMAN, BRENDA LIBBY | 1 | 74.8% | +15.7% |
| ALAWADI, SARAH | 1 | 37.7% | +38.3% |
| DANG, PHUC T | 1 | 95.5% | +1.4% |
| KOVACH, KARA NICOLE | 1 | 85.7% | +100.0% |
| KOLKIN, ADAM D. | 1 | 45.0% | +6.2% |
| WHALEY, PABLO S | 1 | 25.0% | +21.3% |
| GERIDO, DWAN A | 1 | 58.1% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18340240 | MULTI-SPECIES REFERENCE LADDER AND MULTI-PLEX PCR KIT AND USES THEREOF | KOVACH, KARA NICOLE | 26d |
| 18945850 | ANTIFIBROTIC COMPOUNDS AND RELATED METHODS | COLEMAN, BRENDA LIBBY | — |
| 18292258 | NANOPARTICLES AND USES THEREOF FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | ALAWADI, SARAH | — |
| 18533551 | RECONFIGURABLE PACKAGE INTEGRATED ELECTRO MAGNETIC INTERFERENCE SHIELDING | DANG, PHUC T | — |
| 17993282 | FOUR-COMPARTMENT DIFFUSION MODEL OF CORTISOL IN HUMANS | WHALEY, PABLO S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17468966 | SYSTEM AND METHOD FOR LABEL-FREE SINGLE MOLECULE DETECTION | GERIDO, DWAN A | 14d |
| 18340240 | MULTI-SPECIES REFERENCE LADDER AND MULTI-PLEX PCR KIT AND USES THEREOF | KOVACH, KARA NICOLE | 26d |
| 19065557 | PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT | WANG, CHANG YU | — |
| 18945850 | ANTIFIBROTIC COMPOUNDS AND RELATED METHODS | COLEMAN, BRENDA LIBBY | — |
| 18292258 | NANOPARTICLES AND USES THEREOF FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | ALAWADI, SARAH | — |
| 18240681 | PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT | WANG, CHANG YU | — |
| 17993282 | FOUR-COMPARTMENT DIFFUSION MODEL OF CORTISOL IN HUMANS | WHALEY, PABLO S | — |
| Art Unit | Apps |
|---|---|
| 1675 | 2 |
| 1624 | 1 |
| 1619 | 1 |
| 2845 | 1 |
| 1681 | 1 |
| 3798 | 1 |
| 3619 | 1 |
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19065557 | PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT | WANG, CHANG YU | 1675 | Other | Final Rejection | — | Pending | Feb 27, 2025 |
| 18945850 | ANTIFIBROTIC COMPOUNDS AND RELATED METHODS | COLEMAN, BRENDA LIBBY | 1624 | §101DP | Non-Final OA | — | Pending | Nov 13, 2024 |
| 18292258 | NANOPARTICLES AND USES THEREOF FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | ALAWADI, SARAH | 1619 | §103§112 | Non-Final OA | — | Pending | Jan 25, 2024 |
| 18533551 | RECONFIGURABLE PACKAGE INTEGRATED ELECTRO MAGNETIC INTERFERENCE SHIELDING | DANG, PHUC T | 2845 | §101 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18240681 | PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT | WANG, CHANG YU | 1675 | Other | Final Rejection | — | Pending | Aug 31, 2023 |
| 18340240 | MULTI-SPECIES REFERENCE LADDER AND MULTI-PLEX PCR KIT AND USES THEREOF | KOVACH, KARA NICOLE | 1681 | §103§112 | Non-Final OA | 26d | Pending | Jun 23, 2023 |
| 18306012 | SYSTEMS AND METHODS FOR PERFORMING PERIPHERAL VASCULAR IMAGING | KOLKIN, ADAM D. | 3798 | §103 | Non-Final OA | 41d | Pending | Apr 24, 2023 |
| 17993282 | FOUR-COMPARTMENT DIFFUSION MODEL OF CORTISOL IN HUMANS | WHALEY, PABLO S | 3619 | §101§112Other | Final Rejection | — | Pending | Nov 23, 2022 |
| 17468966 | SYSTEM AND METHOD FOR LABEL-FREE SINGLE MOLECULE DETECTION | GERIDO, DWAN A | 1797 | §103 | Final Rejection | 14d | Pending | Sep 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Florida International University Board of Trustees has 9 pending office actions as of October 2026, spread across 8 art units and 8 examiners.
Chang Yu Wang has the most, with 2 of The Florida International University Board of Trustees's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
